07.02.2018 17:36:00
|
GEMCO Medical Announces Brightree Partnership
HUDSON, Ohio, Feb. 7, 2018 /PRNewswire/ -- GEMCO Medical, a distributor for medical supply providers, is pleased to announce its partnership with Brightree®, the leading provider of cloud-based clinical, business management and billing software for the post-acute care industry, as an integrated electronic purchasing partner. The partnership simplifies the ordering process for DME/HME dealers by allowing them to place GEMCO orders directly from the Brightree Integrated ePurchasing platform. This streamlined process allows providers to reduce costs and increase revenue with no additional charge for integration.
"Our focus has always been helping providers help their customers and this partnership provides a more efficient ordering system to do just that," says Richard Keirn, Vice President of GEMCO Medical. "By removing extra steps in the current order process, we can save providers time and money so they can shift their focus."
"Simpler ordering gives valuable time back to HMEs, and provides patients with fresh supplies faster and a better overall therapy experience," said Rob Boeye, Brightree executive vice president, HME. "It's one of many ways Brightree helps HMEs improve and expand their business, and we're excited to help GEMCO customers do just that."
GEMCO Medical customers will now be able to receive the quality product offerings of GEMCO with the seamless electronic ordering power of the Brightree Integrated ePurchasing system. This system allows providers to:
- Place more accurate orders in less time
- Get the most up-to-date product information
- Receive enhanced shipping and tracking capabilities
- Eliminate the need for duplicate order entry on GEMCO and Brightree systems
- Put an end to excessive, resource-draining printing, faxing, and supplier phone calls
To learn more about the integration of GEMCO and Brightree visit www.gemcomedical.com.
About GEMCO Medical:
Since 1992, GEMCO Medical has been offering quality, dependable medical products and customer service to home care medical providers. With over 25 years' experience and over 45 manufacturing partners, GEMCO provides invaluable industry insight and product knowledge offering personalized service with dedicated representatives. GEMCO is headquartered in Hudson, OH. For more information visit www.gemcomedical.com or call 800-733-7976.
About Brightree
Brightree, a wholly owned subsidiary of ResMed (NYSE: RMD, ASX: RMD), is the leading provider of cloud-based software to improve clinical and business performance of post-acute care companies. Ranked one of the top 100 health care IT companies in the U.S., Brightree serves more than 2,200 organizations in the HME, home health, hospice, orthotic and prosthetic, HME pharmacy, home infusion, and rehabilitation home care segments. For more information, visit www.brightree.com or call 1-888-598-7797.
Linda Looby
GemCare Wellness
330-655-8360
llooby@myehcs.com
View original content with multimedia:http://www.prnewswire.com/news-releases/gemco-medical-announces-brightree-partnership-300595161.html
SOURCE GEMCO Medical

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ResMed Inc.mehr Nachrichten
21.02.25 |
S&P 500-Titel ResMed-Aktie: So viel Gewinn hätte ein Investment in ResMed von vor 10 Jahren eingefahren (finanzen.at) | |
07.02.25 |
S&P 500-Wert ResMed-Aktie: Hätte sich eine Investition in ResMed von vor 3 Jahren rentiert? (finanzen.at) | |
31.01.25 |
Börse New York in Rot: S&P 500 notiert letztendlich im Minus (finanzen.at) | |
31.01.25 |
Börse New York in Grün: S&P 500 verbucht am Freitagnachmittag Gewinne (finanzen.at) | |
31.01.25 |
Börse New York in Grün: S&P 500 mit positivem Vorzeichen (finanzen.at) | |
31.01.25 |
Zuversicht in New York: S&P 500-Anleger greifen zum Start des Freitagshandels zu (finanzen.at) | |
31.01.25 |
S&P 500-Wert ResMed-Aktie: So viel hätte eine Investition in ResMed von vor einem Jahr abgeworfen (finanzen.at) | |
29.01.25 |
Ausblick: ResMed öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |
Analysen zu ResMed Inc.mehr Analysen
Aktien in diesem Artikel
ResMed Inc. | 218,80 | -2,19% |
|